Evaluation of bioceramic paste as vital pulp therapy medicament in primary molars

Invivo comparison of Bioceramic paste and Mineral Trioxide Aggregate as vital pulpotomy medicament in primary molars

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011873

Enrollment

Registered

2018-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- dental caries

Interventions

Intervention1: pulpotomy of primary molars using bioceramic paste: bipceramic putty - Endosequence root repair material, Brasselers company, USA was used as pulpotomy medicament and followed up for 12

Eligibility

Inclusion criteria

Inclusion criteria: 1.Primary molars with deep caries lesion without spontaneous or persistent pain. 2.Primary molars with at least two thirds of root length intact and are restorable with stainless steel crowns

Exclusion criteria

Exclusion criteria: 1.Teeth exhibiting the signs and symptoms of chronic infection such as swelling, mobility and sinus tract . 2.Teeth showing radiographic evidence of pathologic root resorption, inter-radicular bone loss, periapical pathology and calcifications in the canal .

Design outcomes

Primary

Measure	Time frame
Evaluation of bioceramic paste as a pulpotomy medicamentTimepoint: Each teeth were evaluated at 3 and 6 months interval	—

Secondary

Measure	Time frame
Evaluation of Bioceramic paste as a pulpotomy medicamentTimepoint: 12 months	—

Countries

India

Contacts

Public Contactkiranmayi thote

vishnu dental college

rayala.chandrasekhar@gmail.com9440402247

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026